PMID: 9542594May 30, 1998Paper

Co-expression of Fas and Fas ligand in malignant glial tumors and cell lines

Acta Neuropathologica
N HusainN T Zervas

Abstract

Fas ligand (FasL) is involved in tumor evasion from the immune system. We analyzed 22 human gliomas for expression of FasL and its receptor, Fas. Positive FasL and Fas immunoreactivity was detected in 13 out of 22 tumors by Western blotting and in 15 out of 22 tumors by immunohistochemistry. Immunohistochemistry also showed that Fas and FasL expression was confined to tumor cells. Co-expression of these molecules was confirmed by Western blotting and immunohistochemistry in 4 of 7 glioma cell lines. Co-expression of FasL and Fas within tumor cells suggests that their contribution in vivo to the process of immune system evasion and tumor cell apoptosis is complex and probably involves additional factors.

Citations

Jan 24, 2004·Brain Research. Brain Research Reviews·Chulhee Choi, Etty N Benveniste
Oct 29, 2000·Neuropathology and Applied Neurobiology·I FerrerS Ambrosio
Dec 21, 2004·Journal of Neurochemistry·Madhavi S Moodbidri, Neelam V Shirsat
Sep 30, 2010·Molecular and Cellular Biology·Yun-Ju LaiFang-Tsyr Lin
May 15, 2013·SpringerPlus·Manabu OnishiIsao Date
Oct 27, 1999·Proceedings of the National Academy of Sciences of the United States of America·N V SomiaI M Verma
Jan 29, 2011·Cancer Letters·Günter Eisele, Michael Weller
Dec 1, 2009·Neurosurgery Clinics of North America·Emilia AlbesianoMichael Lim
Dec 1, 2009·Neurosurgery Clinics of North America·Allen Waziri
Oct 26, 2000·Japanese Journal of Cancer Research : Gann·N ShinouraH Hamada
Apr 25, 2006·Journal of Neuroimmunology·David G WalkerMichael P Pender
Jan 17, 2002·The Journal of Pathology·Tineke TimmerSteven de Jong
Apr 13, 2007·Language, Speech, and Hearing Services in Schools·Jim HenryConnie Black-Pond
Oct 18, 2006·Neurochemical Research·O M OmranAllan J Yates

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis